---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-22-001369"
form_type: "8-K"
ticker: "BHIC"
cik: "0001784440"
company_name: "BioScience Health Innovations, Inc."
filed_at: "2022-11-29T23:59:59+00:00"
generated_at: "2026-06-21T12:22:41.471287+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Nowtransit sells 40,000 Series A convertible preferred shares for $40,000 gross proceeds

## Summary
- Sold 40,000 Series A convertible preferred shares at $1.00/share to an accredited investor, raising $40,000 gross before expenses.
- Each Series A share converts into 3 shares of common stock at holder's election, subject to 4.99% beneficial ownership limitation.
- The 4.99% limitation may be increased to 9.99% upon 61 days' notice.
- Proceeds will be used for working capital and general corporate purposes (implied).

## SEC filing metadata
- accession: 0001185185-22-001369
- form_type: 8-K
- ticker: BHIC
- cik: 0001784440
- company_name: BioScience Health Innovations, Inc.
- filed_at: 2022-11-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1784440/000118518522001369/0001185185-22-001369-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1784440/000118518522001369/nowtransit20221129_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-22-001369
- JSON: https://secwatch.observer/filing/0001185185-22-001369.json
- Plain text: https://secwatch.observer/filing/0001185185-22-001369.txt

## Key facts
- Material Agreements
  BioScience Health Innovations, Inc. entered into Stock Purchase Agreement with an accredited investor valued at $40,000 (effective 2022-11-22).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: an accredited investor
  - Value: $40,000
  - Effective: 2022-11-22
  source text: On November 22, 2022, Nowtransit Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Agreement”) with an accredited investor pursuant to which the Company sold to the purchaser 40,000 shares of the Company’s Series A Convertible Preferred Stock (the “Series A”) at a purchase price of $1.00 per share (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1784440/000118518522001369/0001185185-22-001369-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.